The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. Our credibility is shown through the prestigious advisory board that spend months of hard work creating a new and topical agenda, year on year.
Now in its 14th annual, the World Orphan Drug Congress Europe will continue to bring experts from the whole value chain under one roof, where you get to meet decision makers in the areas that are most applicable for your business offering.
1000+ of potential customers
in attendance there will be opportunities to find contacts who need to find solutions to challenges around the OMP legislation review and EUHTA as well as commercial and scientific issues in evidence generation, regulation, clinical trials, market access, pricing, manufacturing, gene therapy and precision medicine.
This one event will provide you with a one stop progressive scientific and strategic solution to the orphan drugs industry. Now recognised as the
largest and most established multi-stakeholder
rare disease meeting, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape.
We’ve integrated the
directly into every part of the agenda, reflected in in their attendance to our congress year on year, and through our strategic partnerships with
EURORDIS, NORD, RDI, Findacure, FEDER, CIBER-ER
& many more.
Be part of our best year yet.